相关实验视频
Updated: May 24, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.6K
抗性甲状腺癌的分子瘤学当前的治疗方法和前景
François Cherifi1, Ahmad Awada2
1Oncology Medicine department, François Baclesse Center, Caen, France.
Critical reviews in oncology/hematology
|March 5, 2025
概括
甲状腺癌是最常见的内分泌恶性瘤. 本综述探讨了先进的分化,厌塑性和髓性甲状腺癌的分子变化和向治疗方法.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 甲状腺癌 (TC) 是最普遍的内分泌恶性瘤.
- 虽然手术可以治愈大多数患者,但有一部分患者患上了晚期疾病.
- 晚期疾病的治疗从放射性进展到基于分子变化的向治疗.
研究的目的:
- 对差异化甲状腺癌 (DTC),形甲状腺癌 (ATC) 和髓性甲状腺癌 (MTC) 的频繁分子变异进行审查.
- 为了将这些变化与临床测试和批准的治疗方法相关联.
- 讨论甲状腺癌向治疗的临床和临床前前景.
主要方法:
- 文献综述侧重于不同类型的甲状腺癌亚型中的分子变化.
- 分析当前的治疗策略及其分子基础.
- 检查临床试验数据和临床前研究结果.
主要成果:
- 详细概述了特定于DTC,ATC和MTC的常见分子改变.
- 将批准的向疗法映射到已识别的分子驱动因素.
- 确定有前途的临床前目标和正在进行的临床研究.
结论:
- 了解分子变化对于推进甲状腺癌治疗至关重要.
- 针对性疗法在治疗晚期和耐火性甲状腺癌方面具有显著的前景.
- 对分子驱动因素和治疗策略的持续研究对于改善患者治疗结果至关重要.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461
Synthesis and Regulation of Thyroid Hormones
4.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.1K

